Clinical Trial Update: Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating reparixin in patients with myelofibrosis and related myeloproliferative neoplasms; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• Reparixin (reparixin)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF) | Phase 2 | Status: RECRUITING